Summary
The transport of the eight amino acids (phenylalanine, tyrosine, tryptophan, valine, leucine, isoleucine, histidine and methionine) using the large neutral amino acid transporter of the blood-brain barrier (BBB) has been calculated using published kinetic data. The fate of the amino acids has been followed from blood to interstitial space, to cell and through metabolism which included, for tyrosine and tryptophan, the hydroxylases. The system was analysed in terms of flux control coefficients. Since the summation theorem did not hold, the system clearly behaved as a non-homogeneous system. At physiological levels of these eight amino acids, the largest contribution to the control of the flux of tyrosine is given by the hydroxylase step, followed by the diffusional component of the transport across the BBB. For tryptophan it is the hydroxylase step, followed by the carrier-mediated transport across the BBB. For the other amino acids it is the metabolism, followed by the diffusional component of the BBB transport.
These parameters for tyrosine and tryptophan were determined at increased levels of blood phenylalanine, tyrosine or histidine. The flux through tryptophan hydroxylase can be affected by high blood levels of tyrosine and histidine to values also observed in hyperphenylalaninaemia. Since hypertyrosinaemia (type II) and hyperhistidinaemia are not associated with mental retardation, it is concluded that interference with transport across the BBB of tyrosine and tryptophan, as well as the flux through tryptophan hydroxylase leading to the synthesis of 5-hydroxytryptamine, do not contribute to the cause of permanent brain dysfunction in hyperphenylalaninaemia.
It can be calculated that addition of tyrosine to the diet to raise the blood tyrosine level in phenylketonuria patients may have a beneficial effect for the synthesis of neurotransmitters derived from tyrosine.
Similar content being viewed by others
References
Buist, N. R. M., Kennaway, N. G. and Fellman, J. H. Tyrosinemia type II: hepatic cytosolic tyrosine transaminase deficiency (the Richner-Hahnart syndrome). In Bickel, H. and Wachtel, U. (eds.).Inherited Diseases of Amino Acid Metabolism. Recent Progress in the Understanding, Recognition and Management, Thieme Verlag, Stuttgart, 1985, pp. 203–235
Coulombe, J. T., Kammerer, B. L., Levy, H. L., Hirsch, B. Z. and Scriver, C. R. Histidinemia, Part III. Impact, a prospective study.J. Inher. Metab. Dis. 6 (1983) 58–61
Curzon, G. Influence of plasma tryptophan on brain 5HT synthesis and serotogenic activity. In Harker, B., Gabay, S., Issidoris, M. R. and Alivisatos, S. G. A. (eds.)Serotonin. Current Aspects of Neurochemistry and Function, Plenum Press, New York, 1981, pp. 207–219
Ehret, M., Gabaille, S., Cash, C. D., Mandel, P. and Maitrè, M. Regional distribution in rat brain of tryptophan hydroxylase apoenzyme determined by enzyme-linked immunoassay.Neurosci. Lett. 73 (1987) 71–76
Giersch, C. Control analysis of metabolic networks. I. Homogeneous functions and the summation theorems for control coefficients.Eur. J. Biochem. 174 (1988) 509–513
Heinrich, R. and Rapaport, T. A. A linear steady-state treatment of enzymatic chains. General properties, control and effector strength.Eur. J. Biochem. 42 (1974) 97–105
Hjelm, M., Seakins, J., Kitney, R. and Holmes, A. In Bickel, H. and Wachtel, U. (eds.)Inherited Diseases of Amino Acid Metabolism. Recent Progress in the Understanding, Recognition and Management, Thieme Verlag, Stuttgart, 1985, pp. 51–66
Hofmeyer, J. H., Kacser, H. and Van der Merwe, K. J. Metabolic control analysis of moiety-conserved cycles.Eur. J. Biochem. 155 (1986) 631–641
Hommes, F. A. The role of the blood-brain barrier in the aetiology of permanent brain dysfunction in hyperphenylalaninaemia.J. Inher. Metab. Dis. 12 (1989) 41–46
Kacser, H. and Burns, J. A. In Davies, D. D. (ed.)Rate Control of Biological Processes, Cambridge University Press, London, 1973, pp. 65–104
Kacser, H. and Burns, J. A. Molecular democracy: who shares the controls.Biochem. Soc. Trans. 7 (1979) 1149–1161
Koch, R., Gross Friedman, E. and Azen, C. G. Report from the United States collaborative study of children treated for phenylketonuria (PKU). In Bickel, H. and Wachtel, U. (eds.)Inherited Diseases of Amino Acid Metabolism. Recent Progress in the Understanding, Recognition and Management, Thieme Verlag, Stuttgart, 1985, pp. 134–150
Krause, U., Halminski, M., McDonald, L., Dembure, P., Salvo, R., Freides, D. and Elsas, L. Biochemical and neuropsychological effects of elevated plasma phenylalanine in patients with treated phenylketonuria. A model of the study of phenylalanine and brain function in man.J. Clin. Invest. 75 (1985) 40–48
Krause, W., Epstein, C., Averbook, A., Dembure, P. and Elsas, L. Phenylalanine alters the mean power frequency of electroencephalograms and plasmal-DOPA in treated patients with phenylketonuria.Pediatr. Res. 20 (1986) 1112–1116
Lou, H. C. Large doses of tryptophan and tyrosine as potential therapeutical alternative to dietary phenylalanine restriction in phenylketonuria.Lancet 2 (1985) 150–151
Lou, H. C. Increased vigilance and dopamine synthesis effected by large doses of tyrosine in phenylketonuria. In Wurtman, R. J. and Ritter-Walker, E. (eds.)Dietary Phenylalanine and Brain Function, Birkhäuser, Boston, 1988, pp. 254–260
Lou, H. C., Güttler, F., Lykkelund, C., Bruhn, P. and Niederwieser, A. Decreased vigilance and neurotransmitter synthesis after discontinuation of dietary treatment for phenylketonuria in adolescents.Eur. J. Pediatr. 144 (1985) 17–20
Lou, H. C., Lykkelund, C., Gerdes, A. M., Udesen, H. and Bruhn, P. Increased vigilance and dopamine synthesis by large doses of tyrosine and phenylalanine restriction in phenylketonuria.Acta Paediatr. Scand. 76 (1987) 560–565
Lykkelund, C., Nielsen, J. B., Lou, H. C., Rasmussen, V., Gerdes, A. M., Christensen, E. and Güttler, F. Increased neurotransmitter biosynthesis in phenylketonuria by phenylalanine restriction or by supplementation of unrestricted diet with large amounts of tyrosine.Eur. J. Pediatr. 148 (1988) 238–245
Mackay, A. V. P., Davies, P., Dewar, A. J. and Yates, C. M. Regional distribution of enzymes associated with neurotransmission by monoamines, acetycholine and GABA in the human brain.J. Neurochem. 30 (1978) 827–839
Morre, M. C. and Wurtman, R. J. Characteristics of synaptosomal tyrosine uptake in various brain regions: effect of other amino acids.Life Sci. 28 (1981) 65–75
Nakato, H. and Fusijawa, H. Purification and properties of tryptophan-5-monooxygenase from rat brain stem.Eur. J. Biochem. 122 (1982) 41–47
Neckers, L. M. Serotonin turnover and regulation. In Osborn, N. N. (ed.)Biology of Serotonergic Transmission, Wiley, New York, 1982, pp. 139–158
Nelson, T. J. and Kaufman, S. Interaction of tyrosine hydroxylase with ribonucleic acid and purification with DNA cellulose on poly(A)-Sepharose affinity chromatography.Arch. Biochem. Biophys. 257 (1987) 69–84
Nielsen, J. B. Effect of dietary tryptophan supplement on neurotransmitter metabolism in phenylketonuria. In Wurtman, R. J. and Ritter-Walker, E. (eds.)Dietary Phenylalanine and Brain Function, Birkhäuser, Boston, 1988, pp. 261–267
Pardridge, W. M. Kinetics of competitive inhibition of neutral amino acid transport across the blood-brain barrier.J. Neurochem. 29 (1977) 103–108
Pardridge, W. M. Brain metabolism: a perspective from the blood-brain barrier.Physiol. Rev. 63 (1983) 1481–1535
Pardridge, W. M. and Choi, Th.D. Neutral amino acid transport at the human blood-brain barrier.Fed. Proc. 45 (1986) 2073–2078
Pardridge, W. M. and Oldendorf, W. H. Kinetic analysis of blood-brain barrier transport of amino acids.Biochim. Biophys. Acta 410 (1975) 128–136
Pratt, O. E. Kinetics of tryptophan transport across the blood-brain barrier.J. Neurol. Trans. Suppl. 15 (1979) 29–42
Rosenmann, A., Scriver, C. R., Claw, C. L. and Levy, H. L. Histidinaemia, Part II. Impact, a retrospective study.J. Inher. Metab. Dis. 6 (1983) 54–57
Salter, M., Knowles, R. G. and Pogson, C. I. Quantitation of the importance of individual steps in the control of aromatic amino acid metabolism.Biochem. J. 234 (1986) 635–647
Sauro, H. M., Small, J. R. and Fell, D. A. Metabolic control and its analysis. Extension to the theory and matrix method.Eur. J. Biochem. 165 (1987) 215–222
Scriver, C. R. We mean well: treatment of Mendelian disease.Acta Paediatr. Jpn. 30 (1988) 472–480
Scriver, C. R. and Levy, H. L. Histidinaemia, Part I. Reconciling retrospective and prospective findings.J. Inher. Metab. Dis. 6 (1983) 31–53
Smith, Q. R., Momma, S., Aoyogi, M. and Rapaport, S. I. Kinetics of neutral amino acid transport across the blood-brain barrier.J. Neurochem. 49 (1987) 1651–1658
Tada, K., Tateda, H., Arishima, S., Saksi, K., Kitagawa, T., Aoki, K., Suwa, S., Kawamura, M., Oura, T., Takesada, M., Kuroda, Y., Yamashita, F., Matsuda, I. and Naruse, H. Intellectual development in patients with untreated histidinemia.J. Pediatr. 101 (1982) 562–563
Tada, K., Tateda, H., Arishima, S., Saksi, K., Kitagawa, T., Aoki, K., Suwa, S., Kawamura, M., Oura, T., Takesada, M., Kuroda, Y., Yamashita, F., Matsuda, I. and Naruse, H. Followup of a nationwide screening for inborn errors of metabolism in Japan.Eur. J. Pediatr. 142 (1984) 204–207
Tong, J. H. and Kaufman, S. Tryptophan hydroxylase: purification and some properties of the enzyme from rabbit hindbrain.J. Biol. Chem. 250 (1975) 4152–4158
Udenfriend, S., Zultzman-Nirenberg, P. and Nagatsu, T. Inhibitors of purified beef adrenal tyrosine hydroxylase.Biochem. Pharmacol. 14 (1965) 837–845
Voorhees, C. V., Butcher, R. E. and Berry, H. K. Progress in experimental phenylketonuria: a critical review.Neurosci. Behav. Rev. 5 (1980) 177–190
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hommes, F.A., Lee, J.S. The control of 5-hydroxytryptamine and dopamine synthesis in the brain: A theoretical approach. J Inherit Metab Dis 13, 37–57 (1990). https://doi.org/10.1007/BF01799331
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01799331